Astoglial reactivity and metabolism in aging people with HIV

老年艾滋病毒感染者的星形胶质细胞反应性和代谢

基本信息

  • 批准号:
    10846438
  • 负责人:
  • 金额:
    $ 31.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2026-11-30
  • 项目状态:
    未结题

项目摘要

SUMMARY Over 37 million people worldwide are infected with HIV and as many as 50% are affected by some form of neurological dysfunction. Despite effective antiretroviral therapy (ART) extending the lifespans of people with HIV (PWH), treatments to reduce the prevalence of HIV-associated neurocognitive disorder (HAND) and other age-related diseases are lacking. Increased mitochondrial activity in reactive astroglia play a causal role in mitochondrial dysfunction in neurons and this may be a targetable mechanism underlying neuronal dysfunction in virally suppressed PWH, particularly in aging populations. Indeed, there is evidence that aging PWH may be susceptible to age-related diseases such as Alzheimer’s disease (AD). Early during HIV infection, HIV-infected monocytes enter the brain and spread infection to resident microglia that then release HIV, HIV proteins, and inflammatory cytokines, which stimulate a proinflammatory phenotype in astroglia. Reactive astroglia are a hallmark of postmortem brain tissues from HAND and AD. Astroglia have many homeostatic functions, which are likely disrupted by chronic low-level HIV infection, long-term exposure to ART and the age- and AD-related protein beta amyloid (Ab). One important function of astroglia is to buffer the concentrations of metabolic substrates (glucose, lactate, and glutamine) available to neurons in the extracellular space. Despite this crucial function to maintain bioenergetic homeostasis in the brain and the well-documented evidence of bioenergetic deficits during HAND and AD, little is known about how these processes are affected in reactive astroglia. We’ve recently discovered that HIV and ART stimulate a switch in astroglia from being primarily glycolytic and secreting the byproduct lactate, to relying on oxidative phosphorylation to meet energy demands. To achieve this increase in mitochondrial activity, reactive astroglia increase levels of the mitochondrial biogenesis factor TFAM, which is associated with a reduction in TFAM expression and viability in neurons. Importantly, this neurotoxicity is blocked by anti-inflammatory compounds that inhibit mitochondrial activity and reduce the inflammatory phenotype of astroglia. However, the mechanistic link between increased mitochondrial activity in reactive astroglia and the reduction in mitochondrial biogenesis in neurons is not understood. We will investigate the role of astroglial metabolism in aging PWH by testing the hypothesis that the age-related protein Aβ synergizes with HIV, ART and inflammatory cytokines in an age- and TFAM-dependent manner to induce reactive astroglia. SA1 will test in human astrocyte cultures from young and aged donors how TFAM knockdown alters mitochondrial activity and inflammatory gene expression in reactive astroglia. SA2 will investigate in postmortem brain tissues from HIV-, HIV- with AD, and in PWH with and without HAND changes in astroglial TFAM and the relationship with Ab plaques. These AIMs address the Office of AIDS Research Priorities to 1) Address HIV- Associated Comorbidities; and 2) Advance Cross-Cutting Areas of research in the basic and behavioral sciences.
概括 全球有超过 3700 万人感染艾滋病毒,其中多达 50% 的人受到某种形式的影响 神经功能障碍。尽管有效的抗逆转录病毒疗法(ART)可以延长患有此病的人的寿命 HIV (PWH)、降低 HIV 相关神经认知障碍 (HAND) 患病率的治疗和其他 缺乏与年龄有关的疾病。反应性星形胶质细胞中线粒体活性的增加在 神经元线粒体功能障碍,这可能是神经元功能障碍的潜在机制 在病毒抑制的感染者中,特别是在老龄化人群中。事实上,有证据表明,老龄化的产妇可能会 容易患上与年龄相关的疾病,例如阿尔茨海默病(AD)。 HIV感染早期,HIV感染者 单核细胞进入大脑并将感染传播到驻留的小胶质细胞,然后释放 HIV、HIV 蛋白和 炎症细胞因子,刺激星形胶质细胞的促炎表型。反应性星形胶质细胞是 HAND 和 AD 死后脑组织的标志。星形胶质细胞具有许多稳态功能, 可能会受到慢性低水平 HIV 感染、长期接触 ART 以及与年龄和 AD 相关的疾病的干扰 β 淀粉样蛋白 (Ab)。星形胶质细胞的一项重要功能是缓冲代谢物的浓度 细胞外空间神经元可利用的底物(葡萄糖、乳酸和谷氨酰胺)。尽管这至关重要 维持大脑生物能稳态的功能以及生物能的有据可查的证据 尽管 HAND 和 AD 期间存在缺陷,但人们对这些过程如何在反应性星形胶质细胞中受到影响知之甚少。我们已经 最近发现 HIV 和 ART 刺激星形胶质细胞从主要糖酵解和分泌转变 副产物乳酸,依靠氧化磷酸化来满足能量需求。为了实现这一增长 在线粒体活性中,反应性星形胶质细胞增加线粒体生物发生因子 TFAM 的水平,该因子 与神经元中 TFAM 表达和活力的减少有关。重要的是,这种神经毒性被阻断 通过抑制线粒体活性并减少炎症表型的抗炎化合物 星形胶质细胞。然而,反应性星形胶质细胞线粒体活性增加与 神经元线粒体生物发生的减少尚不清楚。我们将研究星形胶质细胞的作用 通过测试年龄相关蛋白 Aβ 与 HIV 协同作用的假设,研究衰老 PWH 中的代谢, ART 和炎症细胞因子以年龄和 TFAM 依赖性方式诱导反应性星形胶质细胞。 SA1 将在年轻和老年捐赠者的人类星形胶质细胞培养物中测试 TFAM 敲低如何改变 反应性星形胶质细胞中的线粒体活性和炎症基因表达。 SA2将进行事后调查 来自 HIV 感染、HIV 感染 AD 以及 PWH 患者的脑组织,无论是否存在 HAND 变化,星形胶质细胞 TFAM 和 与 Ab 斑块的关系。这些目标针对艾滋病研究优先事项办公室:1) 解决艾滋病毒- 相关合并症; 2) 推进基础科学和行为科学的交叉研究领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jerel Adam Fields其他文献

Caloric restriction mimetic 2-deoxyglucose alters metabolic and transcriptomic phenotype in association with changes in chromatin accessibility in human astrocytes
热量限制模拟物 2-脱氧葡萄糖改变了人类星形胶质细胞的代谢和转录组表型,并与染色质可及性的变化相关联
  • DOI:
    10.1038/s41598-025-03796-w
  • 发表时间:
    2025-06-03
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Matthew Spencer;Jacqueline R. Kulbe;Vikram Venkatesh;Anna Laird;Mary Ford;Sydney O’Brien;Ali Boustani;Johannes C. M. Schlachetzki;Jerel Adam Fields
  • 通讯作者:
    Jerel Adam Fields
231. Effects of Tenofovir Alafenamide Fumarate on Inflammatory Markers and Behavior in gp120 Mice
  • DOI:
    10.1016/j.biopsych.2023.02.471
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jacqueline Kulbe;Mary Swinton;Anh Le;Anna Laird;Nicholas Scrivens;Michael Mante;Jazmin Florio;Robert Rissman;Jerel Adam Fields
  • 通讯作者:
    Jerel Adam Fields
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
HIV 相关认知功能障碍的潜在机制及其治疗管理的新兴疗法
  • DOI:
    10.1038/s41582-023-00879-y
  • 发表时间:
    2023-10-10
  • 期刊:
  • 影响因子:
    33.100
  • 作者:
    Ronald J. Ellis;María J. Marquine;Marcus Kaul;Jerel Adam Fields;Johannes C. M. Schlachetzki
  • 通讯作者:
    Johannes C. M. Schlachetzki
Correction: GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice
更正:GP120 和替诺福韦阿拉芬酰胺改变小鼠海马中大麻素受体 1 的表达
  • DOI:
    10.1007/s13365-023-01192-6
  • 发表时间:
    2024-01-04
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    Jacqueline Renee Kulbe;Alexandra Anh Le;Michael Mante;Jazmin Florio;Anna Elizabeth Laird;Mary K. Swinton;Robert A. Rissman;Jerel Adam Fields
  • 通讯作者:
    Jerel Adam Fields

Jerel Adam Fields的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jerel Adam Fields', 18)}}的其他基金

Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV
大麻和影响艾滋病毒血脑屏障功能的致病机制
  • 批准号:
    10683027
  • 财政年份:
    2023
  • 资助金额:
    $ 31.6万
  • 项目类别:
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain
TFAM 改变在 HIV 和 ART 诱导的大脑线粒体功能障碍中的作用
  • 批准号:
    10536678
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain
TFAM 改变在 HIV 和 ART 诱导的大脑线粒体功能障碍中的作用
  • 批准号:
    10403383
  • 财政年份:
    2022
  • 资助金额:
    $ 31.6万
  • 项目类别:
Development of Pirenzepine for HIV-SN
哌仑西平治疗 HIV-SN 的开发
  • 批准号:
    9464143
  • 财政年份:
    2017
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated
HIV-1相关期间线粒体裂变/融合失调的机制
  • 批准号:
    8542439
  • 财政年份:
    2013
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated
HIV-1相关期间线粒体裂变/融合失调的机制
  • 批准号:
    8652197
  • 财政年份:
    2013
  • 资助金额:
    $ 31.6万
  • 项目类别:
Regulation of Astrocyte TIMP-1 in HIV-Associated Dementia
星形胶质细胞 TIMP-1 在 HIV 相关痴呆中的调节
  • 批准号:
    8141024
  • 财政年份:
    2011
  • 资助金额:
    $ 31.6万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 31.6万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 31.6万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 31.6万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 31.6万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 31.6万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 31.6万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 31.6万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 31.6万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 31.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了